MITCHELL DEAN J

PRAX

MITCHELL DEAN J serves as Director at Praxis Precision Medicines, Inc. (PRAX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$122.3K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$122.3K

Companies Traded

PGEN, PRAX

Active Period

Jun 2022 – Sep 2023

3 total trades

Most Recent

Buy PGEN

Sep 25, 2023 · $35.3K

MITCHELL DEAN J's Insider Trading at Praxis Precision Medicines, Inc. (PRAX)

Buys

2 · $87.0K

Sells

0 · $0.00

Total Shares Bought

75,000

Total Shares Sold

PRAX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 27, 2023	Buy	50,000	$0.84	$41.8K	75,000
Jun 9, 2022	Buy	25,000	$1.81	$45.2K	25,000

MITCHELL DEAN J's Insider Trading at Precigen, Inc. (PGEN)

Buys

1 · $35.3K

Sells

0 · $0.00

Total Shares Bought

25,000

Total Shares Sold

PGEN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 25, 2023	Buy	25,000	$1.41	$35.3K	356,836

Related Insiders

Phil Tennant

officer: Chief Commercial Officer

PGENSell · Jun 1, 2026

Helen Sabzevari

officer: President and CEO

PGENSell · Jun 1, 2026

Rutul R Shah

officer: Chief Operating Officer

PGENSell · Jun 1, 2026

Donald P. Lehr

officer: Chief Legal Officer

PGENSell · Jun 1, 2026

Harry Thomasian Jr.

officer: Chief Financial Officer

PGENSell · Jun 1, 2026

KIRK RANDAL J

director, 10 percent owner:

PGENSell · Mar 31, 2026

Alex Nemiroff

General Counsel and Secretary

PRAXSell · Jan 12, 2026

Timothy Edwin Kelly

Chief Financial Officer

PRAXSell · Jan 12, 2026

Explore More Insider Trading Data

PRAX Insider Trading Activity

View all insider trades at Praxis Precision Medicines, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity